Open access
Open access
Powered by Google Translator Translator

EBM & Clinical Trials

Nature journals announce first open-access agreement

21 Oct, 2020 | 09:11h | UTC

Nature journals announce first open-access agreement – Nature

 


Covid-19 vaccine protocols reveal that trials are designed to succeed

20 Oct, 2020 | 01:40h | UTC

Covid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed – Forbes

 


‘No evidence of effect’ versus ‘evidence of no effect’: how do they differ?

20 Oct, 2020 | 01:28h | UTC

‘No evidence of effect’ versus ‘evidence of no effect’: how do they differ? – Students 4 Best Evidence

 

Commentary on Twitter

 


New PLOS pricing test could signal end of scientists paying to publish free papers

18 Oct, 2020 | 23:02h | UTC

New PLOS pricing test could signal end of scientists paying to publish free papers – Science

 


Viewpoint: Sensible medicine—balancing intervention and inaction during the COVID-19 pandemic

16 Oct, 2020 | 09:38h | UTC

Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic – JAMA

Author interview: Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic

 

Commentary on Twitter

 


Researchers worldwide fight to work and teach amid COVID-19

16 Oct, 2020 | 09:35h | UTC

Researchers worldwide fight to work and teach amid COVID-19 – Nature

 


Study: Real-world blood pressure measurements vs. measurements taken in the SPRINT trial

15 Oct, 2020 | 09:00h | UTC

Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice – JAMA Internal Medicine

Commentaries: A Tale of 2 Blood Pressures – JAMA Internal Medicine AND Real-World BP Measurements vs SPRINT Protocol – Physician’s Weekly

 

Commentary on Twitter

 


Perspective: Why does a high-impact publication matter so much for a career in research?

15 Oct, 2020 | 08:56h | UTC

Why does a high-impact publication matter so much for a career in research? – Nature

 


Research integrity: Nine ways to move from talk to walk

13 Oct, 2020 | 01:01h | UTC

Research integrity: nine ways to move from talk to walk – Nature

 


Initiative pushes to make journal abstracts free to read in one place

13 Oct, 2020 | 01:00h | UTC

Initiative pushes to make journal abstracts free to read in one place – Nature

 


Researchers face hurdles to evaluate, synthesize COVID-19 evidence at top speed

12 Oct, 2020 | 00:37h | UTC

Researchers face hurdles to evaluate, synthesize COVID-19 evidence at top speed – Science

 


Three lessons COVID-19 has taught us about Open Access publishing

7 Oct, 2020 | 09:19h | UTC

Three lessons COVID-19 has taught us about Open Access publishing – London School of Economics and Political Science

 


John P.A. Ioannidis: Scientific petitions and open letters in the Covid-19 era

4 Oct, 2020 | 23:27h | UTC

John P.A. Ioannidis: Scientific petitions and open letters in the covid-19 era – The BMJ Opinion

 


India pushes bold ‘one nation, one subscription’ journal-access plan

2 Oct, 2020 | 09:10h | UTC

India pushes bold ‘one nation, one subscription’ journal-access plan – Nature

 


HHMI, one of the largest research philanthropies, will require immediate open access to papers

2 Oct, 2020 | 09:09h | UTC

HHMI, one of the largest research philanthropies, will require immediate open access to papers – Science

Related: UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject)

 


New research shows older adults are still often excluded from clinical trials

1 Oct, 2020 | 09:02h | UTC

New research shows older adults are still often excluded from clinical trials – STAT

Original Study: The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019—Missing the Target – JAMA Internal Medicine

 

Commentary on Twitter

 


Personal experiences or anecdotes (stories) are an unreliable basis for assessing the effects of most treatments

28 Sep, 2020 | 01:24h | UTC

Personal experiences or anecdotes (stories) are an unreliable basis for assessing the effects of most treatments – Evidently Cochrane

 

Commentary on Twitter

 


Harvard University says it can’t afford journal publishers’ prices

28 Sep, 2020 | 01:23h | UTC

Harvard University says it can’t afford journal publishers’ prices – The Guardian

Related: UC Terminates Subscriptions with World’s Largest Scientific Publisher in Push for Open Access (several resources on the subject)

 


Britain will ‘host world’s first Covid-19 vaccine challenge trial’

24 Sep, 2020 | 09:22h | UTC

Britain will ‘host world’s first Covid-19 vaccine challenge trial’: Hundreds of volunteers to be deliberately infected with the coronavirus to speed up tests of experimental jabs – Daily Mail

Commentary: Expert reaction to media reports that COVID-19 human challenge trials will take place in the UK in January – Science Media Centre

 


COVID-19 clinical trials: Learning from exceptions in the research chaos

23 Sep, 2020 | 14:50h | UTC

COVID-19 clinical trials: learning from exceptions in the research chaos – Nature

 

Commentary on Twitter

 

 


Estimating risk ratios and risk differences: Alternatives to odds ratios

17 Sep, 2020 | 09:25h | UTC

Estimating Risk Ratios and Risk Differences: Alternatives to Odds Ratios – JAMA (free for a limited period)

 

Commentary on Twitter

 


When to replicate systematic reviews of interventions: Consensus checklist

17 Sep, 2020 | 09:23h | UTC

When to replicate systematic reviews of interventions: consensus checklist – The BMJ

 

Commentary on Twitter

 


Open letter calls on cardiovascular societies to discourage cardiac magnetic resonance after mild COVID-19

16 Sep, 2020 | 09:09h | UTC

Open Letter Calls on CV Societies to Discourage CMR After Mild COVID-19 – TCTMD

 


UK tests if COVID-19 vaccines might work better inhaled

16 Sep, 2020 | 08:56h | UTC

UK tests if COVID-19 vaccines might work better inhaled – Associated Press

 


Coronavirus: Monoclonal antibodies to begin UK trial

16 Sep, 2020 | 08:53h | UTC

Coronavirus: Monoclonal antibodies to begin UK trial – BBC

See also: Covid-19: RECOVERY trial will evaluate “antiviral antibody cocktail” – The BMJ

 


Stay Updated in Your Specialty

 

No spam, just news.